CYLD mutations are associated with constitutive activation of NF-κB in multiple myeloma cells and B cells from mice deficient for wild-type CYLD exhibited constitutive activation of NF-κB [15,24,25]. This evidence concerns the gene CYLD and plasma cell myeloma.